These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1871801)

  • 1. Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients.
    Kunzendorf U; Walz G; Brockmoeller J; Neumayer HH; Jochimsen F; Roots I; Offermann G; Strom TB
    Transplantation; 1991 Aug; 52(2):280-4. PubMed ID: 1871801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of human peripheral blood mononuclear cell proliferative response by diltiazem : in vitro comparison in younger versus older subjects.
    D'Ambrosio A; Giordani L; Colucci M; Vanacore N; Quintieri F
    Drugs Aging; 2009; 26(1):87-94. PubMed ID: 19102517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study.
    Ladefoged SD; Pedersen E; Hammer M; Rasmussen KC; Hansen FM; Andersen CB
    Nephrol Dial Transplant; 1994; 9(5):543-7. PubMed ID: 8090335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of calcium antagonists in human renal transplantation.
    Neumayer HH; Kunzendorf U; Schreiber M
    Kidney Int Suppl; 1992 May; 36():S87-93. PubMed ID: 1377295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients.
    Bleck JS; Thiesemann C; Kliem V; Christians U; Hecker H; Repp H; Frei U; Westhoff-Bleck M; Manns M; Sewing KF
    Br J Clin Pharmacol; 1996 Jun; 41(6):551-6. PubMed ID: 8799521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
    Chabannes D; Moreau JF; Soulillou JP
    Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem in renal allograft recipients receiving cyclosporine.
    Chrysostomou A; Walker RG; Russ GR; d'Apice AJ; Kincaid-Smith P; Mathew TH
    Transplantation; 1993 Feb; 55(2):300-4. PubMed ID: 8434380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of high lymphocyte sensitivity to glucocorticoids on kidney graft survival in patients treated with azathioprine and cyclosporine.
    Langhoff E; Ladefoged J
    Transplantation; 1987 Mar; 43(3):380-4. PubMed ID: 3547794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation.
    Valantine H; Keogh A; McIntosh N; Hunt S; Oyer P; Schroeder J
    J Heart Lung Transplant; 1992; 11(1 Pt 1):1-7; discussion 7-8. PubMed ID: 1540597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
    Ingsathit A; Sumethkul V; Chalermsanyakorn P; Jirasiritham S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S235-41. PubMed ID: 17044477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipients.
    Xue W; Ding X; Tian P; Pan X; Yan H; Hou J; Feng X; Xiang H; Tian X
    Ren Fail; 2010 Jan; 32(3):314-9. PubMed ID: 20370446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
    Rayat G; Yatscoff R; Silverman R; McKenna R
    Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome.
    Patton PR; Brunson ME; Pfaff WW; Howard RJ; Peterson JC; Ramos EL; Karlix JL
    Transplantation; 1994 Mar; 57(6):889-92. PubMed ID: 8154037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
    Kuhn UD; Lupp A; Kostka E; Kühl A; Balogh A; Stein G; Fleck C
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):484-90. PubMed ID: 9784027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation.
    Neumayer HH; Kunzendorf U; Schreiber M
    Ren Fail; 1992; 14(3):289-96. PubMed ID: 1380721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients.
    Roy LF; East DS; Browning FM; Shaw D; Ogilvie RI; Cardella C; Leenen FH
    Clin Pharmacol Ther; 1989 Dec; 46(6):657-67. PubMed ID: 2689045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants.
    Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK
    Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.